IL249357B - Nanoparticles containing chitosan, their preparation and use - Google Patents

Nanoparticles containing chitosan, their preparation and use

Info

Publication number
IL249357B
IL249357B IL249357A IL24935716A IL249357B IL 249357 B IL249357 B IL 249357B IL 249357 A IL249357 A IL 249357A IL 24935716 A IL24935716 A IL 24935716A IL 249357 B IL249357 B IL 249357B
Authority
IL
Israel
Prior art keywords
chitosan
nanoparticles
antigen
preparation
Prior art date
Application number
IL249357A
Other languages
English (en)
Hebrew (he)
Other versions
IL249357A0 (en
Inventor
Andrea Hanefeld
Markus Weigandt
Michael Wolf
Percy Knolle
Matthias Schroeder
Regina SCHRLIESS
Peter Walden
Andrea Diedrich
Hartwig Steckel
Renato Brito Baleeiro
Original Assignee
Merck Patent Gmbh
Andrea Hanefeld
Markus Weigandt
Michael Wolf
Percy Knolle
Matthias Schroeder
Regina SCHRLIESS
Peter Walden
Andrea Diedrich
Hartwig Steckel
Renato Brito Baleeiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Andrea Hanefeld, Markus Weigandt, Michael Wolf, Percy Knolle, Matthias Schroeder, Regina SCHRLIESS, Peter Walden, Andrea Diedrich, Hartwig Steckel, Renato Brito Baleeiro filed Critical Merck Patent Gmbh
Publication of IL249357A0 publication Critical patent/IL249357A0/en
Publication of IL249357B publication Critical patent/IL249357B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL249357A 2014-06-06 2016-12-04 Nanoparticles containing chitosan, their preparation and use IL249357B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14001974 2014-06-06
PCT/EP2015/000974 WO2015185180A1 (en) 2014-06-06 2015-05-12 Antigen-loaded chitosan nanoparticles for immunotherapy

Publications (2)

Publication Number Publication Date
IL249357A0 IL249357A0 (en) 2017-02-28
IL249357B true IL249357B (en) 2021-01-31

Family

ID=50897334

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249357A IL249357B (en) 2014-06-06 2016-12-04 Nanoparticles containing chitosan, their preparation and use

Country Status (10)

Country Link
US (1) US10369217B2 (enExample)
EP (1) EP3151856B1 (enExample)
JP (1) JP6730937B2 (enExample)
CN (1) CN106456746B (enExample)
AR (1) AR100745A1 (enExample)
AU (1) AU2015271295B2 (enExample)
CA (1) CA2951063C (enExample)
ES (1) ES2754507T3 (enExample)
IL (1) IL249357B (enExample)
WO (1) WO2015185180A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
CN110974805A (zh) * 2019-12-23 2020-04-10 中国科学院海洋研究所 具有增强抗原提呈细胞提呈抗原作用的壳聚糖衍生物纳米粒及制备
GB202018665D0 (en) * 2020-11-26 2021-01-13 Provost Fellows And Scholars Of Trinity College Dublin Immunotherapy for cancer
WO2023168541A1 (en) * 2022-03-09 2023-09-14 Shenzhen Genius Biotech Service Co., Ltd. Chitosan nanoparticles (cnps) and preparation method thereof
WO2024083221A1 (zh) * 2022-10-21 2024-04-25 北京安必奇生物科技有限公司 一种黏膜给药制剂及其制备方法和应用
CN117379393A (zh) * 2023-10-11 2024-01-12 北京安必奇生物科技有限公司 一种核酸药物黏膜给药制剂及其制备方法和应用
CN119506406A (zh) * 2023-08-24 2025-02-25 康希诺生物股份公司 一种表征吸入疫苗性能的方法
CN117398482B (zh) * 2023-09-18 2026-04-24 浙江理工大学 一种卵清蛋白负载硝基自由基氮氧化物纳米复合材料及其制备方法和应用
WO2025209535A1 (en) * 2024-04-03 2025-10-09 Suzhou Xinxin Biopharma Co., Ltd Compositions and associated methods for chitosan-based nano-carriers for therapeutic agents and their applications

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137697B1 (en) * 2004-10-05 2012-03-20 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
ES2259914B1 (es) * 2005-03-14 2007-06-16 Advanced In Vitro Cell Technologies, S.L. Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas.
EP2397123A1 (en) * 2006-07-07 2011-12-21 Aarhus Universitet Nanoparticles for nucleic acid delivery
WO2008039390A2 (en) * 2006-09-22 2008-04-03 Government Of The Usa., Dept. Of Health & Human Services Compositions and methods for chitosan enhanced immune response
WO2010001932A1 (ja) * 2008-07-01 2010-01-07 日東電工株式会社 表面被覆微粒子の医薬組成物
CN107875127A (zh) * 2012-02-28 2018-04-06 艾塞尤提卡控股公司 可吸入药物组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137697B1 (en) * 2004-10-05 2012-03-20 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG HONG ET AL, MONODISPERSE CHITOSAN NANOPARTICLES FOR MUCOSAL DRUG DELIVERY, 30 November 2004 (2004-11-30) *

Also Published As

Publication number Publication date
IL249357A0 (en) 2017-02-28
EP3151856B1 (en) 2019-08-07
AU2015271295B2 (en) 2020-04-16
US10369217B2 (en) 2019-08-06
EP3151856A1 (en) 2017-04-12
JP2017516834A (ja) 2017-06-22
CN106456746A (zh) 2017-02-22
CA2951063A1 (en) 2015-12-10
WO2015185180A1 (en) 2015-12-10
CA2951063C (en) 2022-10-04
AR100745A1 (es) 2016-10-26
JP6730937B2 (ja) 2020-07-29
ES2754507T3 (es) 2020-04-17
AU2015271295A1 (en) 2017-01-19
US20170143822A1 (en) 2017-05-25
CN106456746B (zh) 2021-03-26

Similar Documents

Publication Publication Date Title
IL320713A (en) Antibodies, uses and methods
ZA201704467B (en) Anti-cd47 antibodies and uses thereof
IL252346A0 (en) Heteroaryl compounds, their preparation and use
IL247713A0 (en) Indazole 3-carboxyamides converted at the 5-position, their preparation and their use
PL4036094T3 (pl) Podstawione 4‑fenylopiperydyny, ich wytwarzanie i zastosowanie
EP3124741A4 (en) Self-suspending proppant and preparation and use thereof
IL249357A0 (en) Nanoparticles containing chitosan, their preparation and use
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
EP3107569A4 (en) Anti-acth antibodies and use thereof
GB201408673D0 (en) Medicaments,uses and methods
IL250844A0 (en) Medical nanoparticles and related preparations, methods and systems
PL3040062T3 (pl) Struktura chłonna i artykuł chłonny, zawierający tę strukturę chłonną
IL247531B (en) The history of ksuz, their preparation and uses
IL246896A0 (en) Polyamide nanoparticles and their uses
IL253174A0 (en) Nanoparticles and methods for their preparation
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
HUE047919T2 (hu) Biológiai asszimilációra alkalmas proteo-melanisztikus komplex, készítmény és felhasználásai
IL249073B (en) Cytin-glucan complex, its preparation and uses
ZA201608621B (en) Silicon-containing azodicarboxamides, their preparation and use
PL3233126T3 (pl) Nanocząstki do enkapsulacji związków, ich przygotowanie i zastosowania
PL3122184T3 (pl) Mikrokapsułki chlomazonu, ich wytwarzanie i zastosowanie
GB201520755D0 (en) Nanoparticle formulations and their uses
HK1234324A1 (en) Chitin-glucan complex, its preparation, and uses
AU2015230999A1 (en) 5-substituted indazole-3-carboxamides and preparation and use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed